Colorectal cancer cell-derived extracellular vesicles induce phenotypic alteration of T cells into tumor-growth supporting cells with transforming growth factor-β1-mediated suppression

Nami Yamada; Yuki Kuranaga; Minami Kumazaki; Haruka Shinohara; Kohei Taniguchi; Yukihiro Akao

doi:10.18632/oncotarget.7041

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Colorectal cancer cell-derived extracellular vesicles induce phenotypic alteration of T cells into tumor-growth supporting cells with transforming growth factor-β1-mediated suppression

Nami Yamada _, Yuki Kuranaga, Minami Kumazaki, Haruka Shinohara, Kohei Taniguchi and Yukihiro Akao

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:27033-27043. https://doi.org/10.18632/oncotarget.7041

Metrics: PDF 3467 views | HTML 3668 views | ?

Abstract

Nami Yamada1, Yuki Kuranaga1, Minami Kumazaki1, Haruka Shinohara1, Kohei Taniguchi1 and Yukihiro Akao1

1 United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan

Correspondence to:

Nami Yamada, email:

Keywords: colorectal cancer, exosome, extracellular vesicle, TGF-β1, tumor-stromal interaction

Received: August 20, 2015 Accepted: January 20, 2016 Published: January 27, 2016

Abstract

Emerging studies on tumor cell-derived extracellular vesicles (EVs) have shown the biological significance in tumor development and microenvironment through reprogramming immune cells around cancer cells. In this study, we used colorectal cancer cells as EVs donor, and T cells as recipients to examine whether EVs impair the T cell function. As a result, we found that colorectal cancer cell-derived EVs (CRC-EVs) were enriched with TGF-β1. Interestingly, CRC-EVs induced phenotypic alteration of the T cells to Treg-like cells through activating TGF-β/Smad signaling and inactivating SAPK signaling. Furthermore, the CRC-EVs-induced-Treg-like cells had a remarkable tumor-growth promoting activity in vitro and in vivo. These results suggest that colorectal cancer cells utilize EVs to tame immune cells for their prosperity.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7041

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Colorectal cancer cell-derived extracellular vesicles induce phenotypic alteration of T cells into tumor-growth supporting cells with transforming growth factor-β1-mediated suppression

Abstract